Skip to content

To study effect of Lodhra Churn Lepa in Acne

Assesment of add on effect of Lodhra(Symplocos Racemosa) Churna Lepa in Mukhdushika-RANDOMISED CONTROLLED TRIAL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091268
Enrollment
76
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

PMTS AYURVEDA COLLEGE Shevgaon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENT WITH SIGNS AND SYMPTOMS OF MUKHDUSHIKA. PATIENT WHO GIVES WRITEEN CONSENT.

Exclusion criteria

Exclusion criteria: PATIENT WITH ANAEMIA H LESS THAN 9. PATIENT WHO ARE TAKING ANTICOAGULANT,ANTIPLATELET DRUNGS ETC. PREGNANT AND LACTATING FEMALES. PATIENT WITH H/O CA.DM,HTN,HIV,HBSAG,ALLERGY,BLEEDING DISORDERS ETC.

Design outcomes

Primary

MeasureTime frame
Lodhra Churna Lepa with Jalukvachran is more effective than jalaukavacharan alone in management of MukhdushikaTimepoint: 4 weeks

Secondary

MeasureTime frame
(1) To review literature regarding Jalaukavcharan in Mukhdushika and Acne Vulgaris. (2) To review literature regarding Jalavkavcharan in Mukhdushika. (3) To evaluate the efficacy of Jalaukavcharan in Mukhdushika. (4) To compare efficacy of Lodhra Churna Lepa with Jalaukavcharan and Jalaukavcharan alone. (5) To observe adverse drug reaction if any.Timepoint: 18 Months

Countries

India

Contacts

Public ContactDr Rupali Patil

PMTs Ayurved College Shevgaon

dhootpritam9@gmail.com7588122333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026